Geron will be sold to Roche or Celgene for about $5 a share.
The gamble is just too great, when there are alternative technolgies available (Nickel-Cadium for example). The results are not as striking, but the safest factor goes way up. Air Bus threw in the towel, and Boeing should do the same. A lithium related crash would be very damaging to Boeing. Safe is better than sorry.
If there is good news coming, the management may be worried about lnside trading laws.
Telemeres and Imetelstat--We all know that there has been some very promising results (100% on some blood cancer disorders and some promise with solid tumors). We also know that some major (deep pockets) drug companies are interested. Why has it been so quiet lately?
I think the future of telemeres and Imelestat is yet to be written. All that I know, this looks promising for Geron, and it has at least the potential to be a commercial success in the short run. The data may turn against Geron in the the future, but, to date, there is 100% positive results in certain blood diseases, and some positive results with solid tumors.
Cisco is the future with its focus on "the cloud" and the smart-grid. The sequester may have some strong redeeming features if it can bring the defense department down a size or two, by eliminating military waste
and other duplications.